BIP Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$335K Sell
430
-17
-4% -$13.2K 0.13% 38
2025
Q1
$369K Buy
447
+59
+15% +$49.1K 0.16% 38
2024
Q4
$300K Buy
+388
New +$321K 0.13% 40

Other funds holding LLY

BIP Alliance's LLY Position: Q2 2025 in Review

BIP Alliance reduced its Eli Lilly (LLY) stake by 3.8% in Q2 2025, selling an estimated $13.2K and leaving 430 shares worth $335K. The position accounts for 0.13% of the portfolio, ranked #38.

BIP Alliance first reported a position in LLY in Q4 2024 and has held it in 3 quarters since. The position peaked at $369K in Q1 2025. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • BIP Alliance held 430 shares of Eli Lilly worth $335K as of Q2 2025.
  • BIP Alliance sold 17 Eli Lilly shares in Q2 2025, an estimated $13.2K.
  • Eli Lilly made up 0.13% of BIP Alliance's portfolio in Q2 2025, its #38 holding.
  • BIP Alliance first reported a position in Eli Lilly in Q4 2024 and has held it in 3 quarters since.
  • BIP Alliance's Eli Lilly position peaked at $369K in Q1 2025.
  • 3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on BIP Alliance's 13F filing for Q2 2025, filed 31 Jul 2025.